These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8962263)

  • 1. Etretinate (Ro 10-9359) prevents autoimmune syndrome associated with chronic graft-versus-host disease in rats.
    Stosić-Grujicić S; Ejdus L; Mijatović S; Jovanović S; Ostojić NS
    Transplant Proc; 1996 Dec; 28(6):3258. PubMed ID: 8962263
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease.
    Chen F; Maldonado MA; Madaio M; Eisenberg RA
    J Immunol; 1998 Dec; 161(11):5880-5. PubMed ID: 9834067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular requirements for the induction of insulitis in chronic graft-versus-host disease.
    Ejdus L; Djordjević J; Ostojić N; Stosić S; Lukić ML
    Transplant Proc; 1993 Oct; 25(5):2837. PubMed ID: 8105584
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].
    Salomon B
    J Soc Biol; 2002; 196(4):263-6. PubMed ID: 12645292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
    Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
    Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity.
    Zhao Y; Rodriguez-Barbosa JI; Shimizu A; Sachs DH; Sykes M
    Transplantation; 2003 Jun; 75(11):1832-40. PubMed ID: 12811242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
    Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of recombinant interleukin-2 (rIL-2) and large granular lymphocytes (LGLs) in acute rat graft-versus-host disease (GVHD).
    Clancy J; Goral J; Kovacs EJ; Ellis T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):88-9. PubMed ID: 2784908
    [No Abstract]   [Full Text] [Related]  

  • 17. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.
    Xystrakis E; Bernard I; Dejean AS; Alsaati T; Druet P; Saoudi A
    Eur J Immunol; 2004 Feb; 34(2):408-17. PubMed ID: 14768045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic intrabone marrow-bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats.
    Koike Y; Adachi Y; Suzuki Y; Iwasaki M; Koike-Kiriyama N; Minamino K; Nakano K; Mukaide H; Shigematsu A; Kiyozuka Y; Tubura A; Kamiyama Y; Ikehara S
    Stem Cells; 2007 Feb; 25(2):385-91. PubMed ID: 17284650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
    Mutis T; Aarts-Riemens T; Verdonck LF
    Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.